Next Article in Journal
Improving Water Solubility and Skin Penetration of Ursolic Acid through a Nanofiber Process to Achieve Better In Vitro Anti-Breast Cancer Activity
Next Article in Special Issue
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Previous Article in Journal
Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
Previous Article in Special Issue
Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(9), 1146; https://doi.org/10.3390/pharmaceutics16091146
Action Date Notes Link
article pdf uploaded. 29 August 2024 15:01 CEST Version of Record https://www.mdpi.com/1999-4923/16/9/1146/pdf-vor
article xml file uploaded 30 August 2024 10:19 CEST Original file -
article xml uploaded. 30 August 2024 10:19 CEST Update https://www.mdpi.com/1999-4923/16/9/1146/xml
article pdf uploaded. 30 August 2024 10:19 CEST Updated version of record https://www.mdpi.com/1999-4923/16/9/1146/pdf
article html file updated 30 August 2024 10:20 CEST Original file https://www.mdpi.com/1999-4923/16/9/1146/html
Back to TopTop